Noncanonical STAT3 Activation Regulates Excess TGF-β1 and Collagen I Expression in Muscle of Stricturing Crohn’s Disease
- 1 April 2015
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 194 (7) , 3422-3431
Abstract
Increased TGF-β1 and TGF-β1–dependent Collagen I production in intestinal mesenchymal cells result in fibrosis in patients with Montreal B2 fibrostenotic Crohn’s disease. Numerous cytokines, including IL-6, are produced by activated mesenchymal cells themselves and activate STAT3. The aim of the current study was to determine the mechanisms by which STAT-3 activation might result in intestinal fibrosis. Cytokine levels were measured by ELISA. STAT3 and suppressor of cytokine signaling 3 protein levels were measured by immunoblot, STAT3-TGFB1 DNA–binding activity by chromatin immunoprecipitation, and TGFB1 transcriptional activity by luciferase reporter assay. TGF-β1 (TGFB1), Collagen1α1, and connective tissue growth factor (CTGF) gene expression was measured by quantitative RT-PCR. The role of STAT3 activation was determined using STAT3 inhibitor, Stattic, and by transfection of STAT3 mutants. Autocrine production of cytokines was increased in muscle cells of B2 phenotype patients from strictures and normal intestine in the same patient and compared with other Crohn’s phenotypes, ulcerative colitis, and non-Crohn’s patients. A unique pattern of STAT3 phosphorylation emerged: high STAT3(S727) and low STAT3(Y705) in strictures and the opposite in unaffected intestine. TGFB1 transcriptional activity was regulated by phospho-STAT3(S727) and was decreased by Stattic or dominant-negative STAT3(S727A). TGF-β1, COL1A1, and CTGF expression was inhibited by Stattic or dominant-negative STAT3(S727A). Treatment of normal muscle cells with IL-6 or expression of constitutively active STAT3(S727E) phenocopied muscle cells from strictured intestine. Neutralization of autocrine IL-6 reversed STAT3 phosphorylation and normalized expression of TGF-β1 in strictured intestinal muscle. The ability of Stattic to improve development of fibrosis was confirmed in mice with 2,4,6-trinitrobenzenesulfonic acid–induced colitis. We observed a unique phospho-STAT3(S727) response in patients with Montreal B2 Crohn’s disease, particularly in response to IL-6 leading to increased TGF-β1, collagen, and CTGF production in ileal strictures.Keywords
This publication has 51 references indexed in Scilit:
- Inborn Errors of Human JAKs and STATsImmunity, 2012
- Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel diseaseNature Genetics, 2011
- Distinct and overlapping genetic loci in crohnʼs disease and ulcerative colitis: Correlations with pathogenesisInflammatory Bowel Diseases, 2011
- Amelioration of excess collagen IαI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I(+/−) miceInflammatory Bowel Diseases, 2011
- Lysine methylation of promoter-bound transcription factors and relevance to cancerCell Research, 2010
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociNature Genetics, 2010
- Strong Evidence of a Combination Polymorphism of the Tyrosine Kinase 2 Gene and the Signal Transducer and Activator of Transcription 3 Gene as a DNA-Based Biomarker for Susceptibility to Crohn’s Disease in the Japanese PopulationJournal of Clinical Immunology, 2009
- Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn DiseaseThe American Journal of Human Genetics, 2009
- Paradigm shifts in the cell biology of STAT signalingSeminars in Cell & Developmental Biology, 2008
- IL-6 signaling via the STAT3/SOCS3 pathway: Functional Analysis of the Conserved STAT3 N-domainMolecular and Cellular Biochemistry, 2006